Skip to content

Clinical trials

Completed Hemophilia A trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemophilia A Status: Completed Country / region: China Clear all

40 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20112
20122
20131
20142
20154
20161
20171
20186
20192
20204
20217
20222
20234
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed40

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer5
Hangzhou Gensciences Biopharmaceutical Co., Ltd.5
Pfizer5
Genzyme, a Sanofi Company4
Novo Nordisk A/S4
Staidson (Beijing) Biopharmaceuticals Co., Ltd4
Baxalta now part of Shire3
Hoffmann-La Roche3
Zhengzhou Gensciences Inc2
Andrea Doria1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemophilia A40
Hemophilia B5
Blood Coagulation Disorders2
Blood Coagulation Disorders, Inherited2
Coagulation Protein Disorders2
Genetic Diseases, Inborn2
Genetic Diseases, X-Linked2
Hematologic Diseases2
Hemorrhagic Disorders2
Hemorrhage1

Trials

Showing 1 to 25 of 40. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.